The HR indicated a reduced risk for all-cause mortality in the rosuvastatin group in those with lowest OPG values ( tertile 1 , HR = 0.66 unadjusted [ P = 0.025 ] ; HR = 0.71 Cox adjusted [ P = 0.025 ] ; interaction by treatment effect for the tertiles P = 0.086 ) .
